Erratum to: P53 immunoexpression as a prognostic marker for human astrocytomas: a meta-analysis and review of the literature

By Levidou Georgia   El-Habr Elias   Saetta Angelica   Bamias Christine   Katsouyanni Klea   Patsouris Efstratios   Korkolopoulou Penelope  

Journal of Neuro-Oncology, Vol. 100, Iss. 3, 2010-12 ,pp. : 373-373

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic Value of Mdm2, p53 and p16 in Patients with Astrocytomas

By Ranuncolo Stella   Varela Mirta   Morandi Ana   Lastiri José   Christiansen Silvia   Bal de Kier Joffé Elisa   Pallotta María   Puricelli Lydia  

Journal of Neuro-Oncology, Vol. 68, Iss. 2, 2004-06 ,pp. : 113-121

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic significance of p53 immunoexpression in the survival of oral squamous cell carcinoma patients treated with surgery and neoadjuvant chemotherapy

By      

Oncology Letters, Vol. 6, Iss. 6, 2013-01 ,pp. : 1611-1615

Spandidos Publications

Access to resources Recommend Favorite

p53 codon 72 polymorphism and breast cancer risk: A meta-analysis

By        

Experimental and Therapeutic Medicine, Vol. 5, Iss. 5, 2013-01 ,pp. : 1397-1402

Spandidos Publications

Access to resources Recommend Favorite

Prognostic Biomarkers in Patients with Resected Cholangiocarcinoma: A Systematic Review and Meta-analysis

By Ruys Anthony   Groot Koerkamp Bas   Wiggers Jimme   Klümpen Heinz-Josef   ten Kate Fiebo   Gulik Thomas  

Annals of Surgical Oncology, Vol. 21, Iss. 2, 2014-02 ,pp. : 487-500

Springer Publishing Company

Access to resources Recommend Favorite